Psoriasis Uncovered

Topicals are the most commonly used therapy for psoriasis. Hear why and what the therapy options are during a discussion of the sixth "Guidelines of Care for the Management of Psoriasis" from dermatologist Dr. Elizabeth Prater, Medical Director, Healthy Skin Dermatology in Oklahoma City. Includes a quick discussion of alternative medicine. This guideline activity is supported by grant funding from Bausch Health Foundation, Celgene and Novartis.

Have you or a family member recently transitioned to Medicare or have questions about out-of-pocket costs for prescription drugs? Listen as NPF staff discuss the common challenges the psoriatic disease community commonly experience with Medicare Part D. Learn more about Part D's structure, if the donut hole has really closed, and options to address your out-of-pocket costs. Visit psoriasis.org/take-action for more information on NPF's advocacy.

When the pandemic shut down New York, Cindy found herself working and schooling her sons at home and managing her psoriasis. Fortunately, she discovered telehealth. Hear her story, and Dr. Jennifer Soung who uses telehealth in her practice, as they provide their perspectives on virtual healthcare. This podcast is sponsored by Amgen. For important Safety Information: https://bit.ly/2CzZ6Ym and for Prescribing Information: https://bit.ly/3hclnuA.

Feeling stress, anxiety or depression? Hear Dr. Theodore Stern, Chief of the Avery D. Weisman, Psychiatry Consultation Services at Harvard Medical School, and Dr. Arianne Shadi Kourosh, Assistant Professor of Dermatology at Harvard Medical School discuss strategies you can use to change your perspective of such emotions to truly face psoriatic disease. This episode is supported by unrestricted educational grants from Lilly and Novartis.

Have you ever had to try other medications before you get the one you and your doctor originally chose? This is called step therapy. Listen to this podcast to learn how NPF and others are advocating for federal step therapy legislation called the "Safe Step Act". Learn more at psoriasis.org/take-action or if you are experiencing step therapy, contact the Patient Navigation Center at education@psoriasis.org.

Hear the facts about this controversial and rapidly evolving topic, medical use of cannabis-based products for chronic pain with dermatologist Dr. Jason Hawkes, Assistant Professor of Dermatology at the University of California, Davis. Listen to Dr. Hawkes discussion about key components, actions, effects, interactions and how it relates to chronic pain in psoriatic disease.

Listen as pulmonologist, Dr. Albert Rizzo, Chief Medical Officer at the American Lung Association and member of Christiana Care Pulmonary Associates in Newark, DE, and Deb Brown, Chief Mission Officer with the American Lung Association, discuss the relationship between lung health, systemic inflammation and psoriasis. This episode also includes a free special offer for our listeners from the American Lung Association! Listen to learn more about this free offer!

Take action during Psoriasis Action Month by learning why it's important to participate in the PsoProtectMe global survey. Hear from Professor Catherine Smith, Professor of Dermatology and Therapeutics and Consultant Dermatologist, and Dr. Satveer Mahil, a Consultant Dermatologist, from St. John's Institute of Dermatology, Kings College London, about how this survey can advance our understanding of COVID-19 and other factors that impact the management of psoriasis and psoriatic arthritis.

With COVID-19 telehealth became more prevalent in use and with this pivot came challenges and benefits. Hear dermatologist Dr. George Han, System Medical Director for Dermatology at Mount Sinai Health System and Chief of Teledermatology at Icahn School of Medicine at Mount Sinai, discuss the challenges and tips for making telehealth visits with psoriatic disease a successful experience. This Psound Bytes activity is supported by charitable contributions from Amgen, Janssen Pharmaceutical Companies of Johnson and Johnson, and Novartis.

Dr. Kenneth Gordon, a leading dermatologist and expert in psoriasis treatment, shares insights on oral agents for managing psoriasis. He discusses the factors influencing patients' choices for oral medications, highlighting the efficacy of treatments like methotrexate and apremilast. The conversation delves into cyclosporine's rapid effectiveness and the promise of newer options like tofacitinib. Dr. Gordon also offers an optimistic view on future non-biologic therapies, including fumaric acid esters, which are gaining traction in Europe.